Historically, patient-reported outcome measures were primarily utilized for research purposes in orthopedics.However, renewed ...

ECOG performance status was found to capture only part of the patient experience in gastric/GEJ adenocarcinoma. Among patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma, those ...

Analysis of the phase 3 explorer7 (NCT04083781) study indicates a preference for concizumab prophylaxis over no prophylaxis in patients with hemophilia A or B with inhibitors. Among individuals with ...

Measuring treatment success in Sjögren's disease requires more than tracking systemic disease activity alone. Fatigue, pain, dryness, and daily function often drive patients' quality of life and may ...

Patient-reported fatigue prior to cancer treatment could be used as a biomarker for identifying which individuals will develop serious or fatal adverse events.A retrospective analysis showed patients ...

The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.

Pooled trial data show gepotidacin provides early, meaningful symptom relief comparable to nitrofurantoin in uncomplicated ...

Improved QOL is observed in patients over two years post-infusion and those without disease progression, highlighting the ...

A recent study reveals comparable outcomes for radical cystectomy and bladder-sparing therapy in treating recurrent ...